Wacker Biotech
Engage the CDMO Experts in Advanced Therapies & Biologics Manufacturing
We are passionate about working closely with our customers to develop the next generation of advanced therapeutics, for the benefit of treating, curing, and preventing diseases for patients worldwide.
Contact usExpert source for
・pDNA
・RNA-based therapeutics
・Vaccines
・Live microbial products (LMPs)
・Proteins based on microbial systems
Better with WACKER
Our services cover:
・Strain development
・Cell banking
・Process development
・Analytical development
・GMP manufacturing
A Global CDMO Backed by a Science-Driven Powerhouse
Your needs are driving our innovation! Our five GMP-compliant facilities located in Germany, the Netherlands and United States are closely supported by corporate R&D team of our mother company Wacker Chemie AG. In close collaboration with universities and research institutions, the team of more than 180 researchers innovates new technologies and partnerships. Competitive, outstanding solutions are our trademarks.
- 30+ Years of Experience
- 1,000+ Batches On-Time and On-Budget
- 4 Innovative Production Platforms
- 200+ Client Projects
- 5 Commercial Releases
- 200+ Active Patents and Applications
Amsterdam, The Netherlands
Home to our original mRNA Center of Excellence, the Amsterdam facility provides capabilities for developing mRNA-based processes and GMP manufacturing of customized mRNA processes while also specializing in contract manufacturing of biopharmaceutical proteins, vaccines and Live Biotherapeutic Products based on microbial systems. The site has a 250 L stirred single-use bioreactor and 1500 L stainless-steel stirred fermenter for GMP manufacturing, plus 7-20 L glass stirred single-use fermenters.
Click here to access our virtual plant tour
Learn moreHalle an der Saale, Germany
Our Halle facility is located on the Weinberg campus, one of Europe's leading life sciences hubs. Halle has years of experience and expertise in the production of recombinant proteins and is Wacker Biotech’s competence center for in-vitro protein refolding. It has a 1,500 L stainless-steel stirred-tank fermenter for GMP production plus several single-use fermenters at 5 L, 15 L and 150 L volumes. The site collaborates with the Halle TGZ (technology and startup center) and the many universities, companies, and institutes that innovate at the Weinberg Campus.
The Halle site is now home to a second facility, a high-end, dedicated mRNA competence center that opened in June 2024. The plant consists of four independent GMP lines (2 x 30 L and 2 x 3 L) with high production volume and state-of-the-art process design capabilities.
Click here to access our virtual plant tour
Learn moreJena, Germany
Our original, flagship site, Jena is situated on the Beutenberg science campus close to Friedrich Schiller University and various scientific research institutes. It specializes in the contract manufacturing of recombinant proteins and pharmaceutical actives for clinical testing and the commercial market. It has a 350 L stainless-steel fermenter plus various single-use fermenters.
Click here to access our virtual plant tour
Learn moreSan Diego, California, USA
Our San Diego facility specializes in pDNA production and offers extensive process development services, while also gearing up to offer mRNA and protein production. It has 6 L through 43 L flex-scale single-use bioreactors and a 650 L stainless-steel fermentation vessel, including continuous cell lysis. Corresponding primary recovery and downstream capabilities are available to suit various customer needs.
Learn moreOur mission is to guide you from concept to commercialization of your product. With our commitment to quality, we strive to meet the highest standards while collaborating with clients on their projects.
Expert Insights
Read articles and watch videos with insights from our leaders on the latest challenges and developments in biologics process development and manufacturing.
Learn more
